RRRosa Margarita Gélvez Ramírez

Rosa Margarita Gélvez Ramírez

*This is an algorithmically generated author record based on publicly available information.

Rosa Margarita Gélvez Ramírez has a total of 148 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Maternal Zika virus exposure and neurodevelopmental outcomes: A longitudinal study of preschool children in the ZIKAlliance Colombian Cohort

    by Víctor Herrera, María Consuelo Miranda, Anyela Lozano-Parra, Diana Niño, Luis Ángel Villar, Rosa Margarita Gélvez Ramírez, Thomas Jaenisch, Laura Pezzi, Claudia Acevedo, Jürg Niederbacher

    Background: Zika virus (ZIKV) infection has been inconsistently associated with neurodevelopmental delay (ND). We aimed to compare the incidence of ND between ZIKV-exposed and ZIKV-unexposed children within the ZIKAlliance (ZA) cohort, in Colombia, assessed 2 years after birth (2018–2021). Methods: We performed a neurodevelopmental evaluation on normocephalic children (aged 40–72 months) from the ZIKAlliance cohort. Children were classified as ZIKV-exposed (maternal positive RT-qPCR or virus neutralization test – VNT) or unexposed (maternal negative IgG ELISA or VNT in paired antenatal samples). A trained psychologist, blinded to exposure status, administered the Denver Developmental Screening Test II (DDST-II). Children were considered at ND risk if they presented ≥1 delay or ≥2 cautions in one or more areas, within their age range in the DDST-II scale. Inconclusive initial tests were re-evaluated. Adjusted odds ratios were estimated using logistic regression. Results: We analyzed conclusive DDST-II results from 153 children (mean age: 4.7 years; 53.8% male). Overall, 57.2% (n = 83) were classified as cases of ND. Children with ND were more likely to be male (61.4% versus 43.5%) and less likely to attend daycare or school (42.2% versus 11.3%) than children with normal development. After adjusting for child age, sex, household size, and education, the association between in utero ZIKV exposure and ND was not statistically significant (OR = 0.71; 95% CI: 0.32–1.59, p = 0.320). However, children attending daycare or school had a significantly lower risk of ND compared to those who stayed at home. Conclusions: Prenatal ZIKV exposure was not associated with ND in this cohort of normocephalic preschool children. Instead, attending a community daycare or school emerged as a significant protective factor against developmental delays.


  • Open Access

    Increased threat of urban arboviral diseases from Aedes aegypti mosquitoes in Colombia

    by Rosa Margarita Gélvez Ramírez, Chloé Bohers, Laurence Mousson, Yoann Madec, Marie Vazeille, Géraldine Piorkowski, Sara Moutailler, Francisco J Diaz, Guillermo Rúa-Uribe, Luis Angel Villar, et al.


  • Open Access

    Evaluating vector competence for Yellow fever in the Caribbean

    by Gaelle Gabiane, Chloé Bohers, Laurence Mousson, Thomas Obadia, Rhoel R. Dinglasan, Marie Vazeille, Catherine Dauga, Marine Viglietta, André Yébakima, Anubis Vega-Rúa, et al.

    The mosquito-borne disease, Yellow fever (YF), has been largely controlled via mass delivery of an effective vaccine and mosquito control interventions. However, there are warning signs that YF is re-emerging in both Sub-Saharan Africa and South America. Imported from Africa in slave ships, YF was responsible for devastating outbreaks in the Caribbean. In Martinique, the last YF outbreak was reported in 1908 and the mosquito Aedes aegypti was incriminated as the main vector. We evaluated the vector competence of fifteen Ae. aegypti populations for five YFV genotypes (Bolivia, Ghana, Nigeria, Sudan, and Uganda). Here we show that mosquito populations from the Caribbean and the Americas were able to transmit the five YFV genotypes, with YFV strains for Uganda and Bolivia having higher transmission success. We also observed that Ae. aegypti populations from Martinique were more susceptible to YFV infection than other populations from neighboring Caribbean islands, as well as North and South America. Our vector competence data suggest that the threat of re-emergence of YF in Martinique and the subsequent spread to Caribbean nations and beyond is plausible.


  • Open Access

    Experience in the validation of a rapid test for NS1 and IgM for early diagnosis during a dengue epidemic in Colombia

    by Rosa-Margarita Gélvez Ramírez, Mónika Patricia Consuegra, María Isabel Estupiñan, Adriana Torres Rangel, Víctor Mauricio Herrera, Xavier de Lamballerie, Luis Ángel Villar Centeno

    Dengue has a broad spectrum of syndromic presentations, making clinical diagnosis difficult in regions where acute febrile syndrome has multiple etiologies. Rapid tests for detecting NS1 and IgM are broadly proposed for the early diagnosis of dengue; however, their implementation in primary care settings is inconsistent, and the relevance of IgM detection in this context has not been firmly established. Our study aimed to describe the experience of validating an NS1-IgM rapid test in primary care settings in Bucaramanga, Colombia, during a dengue epidemic (2018 to 2020). We tested blood samples from 568 patients with a clinical diagnosis of dengue using the Bioline Dengue Duo rapid test and RT-PCR as a reference to estimate sensitivity, specificity, and positive and negative predictive values (SE, SP, PPV, and NPV, respectively). The prevalence of infection was 32.9% (95%CI: 29.1, 36.8), whereas SE and SP were 83.4% and 72.7% for NS1 without statistical heterogeneity across disease duration. NS1’s PPV and NPV were 60.0% and 89.9% at the observed prevalence. Our results show that NS1 and IgM rapid tests (POCT) are feasible in the primary care setting. The contribution of the NS1 test was indisputable, with high-performance levels far superior to those of the IgM test. The NS1+IgM combination did not offer a significant advantage over NS1 alone.

  • Open Access

    Estimating the risk of Yellow fever in the Caribbean using vector competence data

    by Gaelle Gabiane, Chloé Bohers, Laurence Mousson, Thomas Obadia, Rhoel Dinglasan, Marie Vazeille, Catherine Dauga, Marine Viglietta, André Yebakima, Anubis Vega-Rúa, et al.

    Mosquito-borne diseases are spreading globally due to the expansion of the geographic range of competent mosquito vector species and increased human movement, especially infected travelers from endemic to non-endemic regions. Yellow fever (YF) has been largely controlled via mass delivery of an effective vaccine and mosquito control interventions. However, there are warning signs that YF is re-emerging in both Sub-Saharan Africa and South America. Imported from Africa to the Americas in slave ships, YF was responsible for devastating urban outbreaks for several centuries. In the Caribbean, the last YF outbreak was reported in 1908 in Martinique. The mosquito Aedes aegypti is the main vector for urban transmission in YF-endemic regions. However, it is unclear if all Ae. aegypti populations can effectively vector yellow fever virus (YFV), as there is growing evidence that intrinsic virus and mosquito host factors can significantly influence arbovirus transmission. We evaluated the vector competence of fifteen Ae. aegypti populations (nine from Martinique, two from Haiti, one from Guadeloupe, one from Cuba, one from Florida (USA), and one from Colombia) for five YFV genotypes (Bolivia, Ghana, Nigeria, Sudan, and Uganda) at 14 and 21 days post-infectious feeding. Mosquito populations from the Caribbean and the Americas were able to transmit the five YFV genotypes, in some cases achieving viral loads in mosquito saliva of up to several thousands of infectious virus particles, with YFV strains for Uganda and Bolivia having higher transmission success. We also observed that Ae. aegypti populations from Martinique were more susceptible to YFV infection than other populations from neighboring Caribbean islands, as well as North and South America. Our vector competence data suggest that the threat of re-emergence of YF in Martinique and the subsequent spread to Caribbean nations and beyond is plausible.

  • Dietary Patterns and Anti-Flavivirus IgG Seroconversion in Colombian Children

    by Tina Arjomand, Oscar F. Herrán, Laura C. Mantilla, María Isabel Estupiñán, Anyela Lozano-Parra, Rosa Margarita Gelvez, Víctor M. Herrera, Luis A. Villar, Eduardo Villamor

    The burden of flaviviral infections, especially dengue and Zika, is high in the Americas. Malnutrition affects the risk and response to infections, but the role of diet on flaviviral infection risk is uncertain. The objective of this study was to investigate the relations between dietary patterns adherence and anti-flavivirus IgG seroconversion in children during a Zika epidemic in a dengue-endemic area of Colombia. In 2015–2016, we followed 424 anti-flavivirus IgG seronegative children aged 2 to 12 years for 1 year. Baseline data included children’s sociodemographic, anthropometric, and dietary information collected through a 38-item food frequency questionnaire (FFQ). IgG testing was repeated at the end of follow-up. The primary exposure was adherence to each of four dietary patterns (animal foods, traditional, ultraprocessed foods, and prudent) that were identified from the FFQ through principal component analysis. Secondary exposures were intake frequencies of foods contributing to relevant patterns. We estimated risk of seroconversion by quartiles of adherence scores and compared them using relative risks (RR) and 95% CI from Poisson regression adjusted for sex, age, and socioeconomic status indicators. Seroconversion risk was 32.1%. Adherence to the traditional pattern was positively related to seroconversion. RR comparing fourth versus first quartiles of adherence was 1.52 (95% CI: 1.04–2.21; P trend = 0.02). Of the most representative foods in this pattern, potato and sugarcane water intake frequencies were related to increased seroconversion risk. In conclusion, adherence to a traditional foods pattern, including potatoes and sugarcane water, was positively associated with anti-flavivirus IgG seroconversion.

  • Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics

    by Makeda L. Robinson, David R. Glass, Veronica Duran, Olga Lucia Agudelo Rojas, Ana Maria Sanz, Monika Consuegra, Malaya Kumar Sahoo, Felix J. Hartmann, Marc Bosse, Rosa Margarita Gelvez, et al.

    Approximately 5 million dengue virus–infected patients progress to a potentially life-threatening severe dengue (SD) infection annually. To identify the immune features and temporal dynamics underlying SD progression, we performed deep immune profiling by mass cytometry of PBMCs collected longitudinally from SD progressors (SDp) and uncomplicated dengue (D) patients. While D is characterized by early activation of innate immune responses, in SDp there is rapid expansion and activation of IgG-secreting plasma cells and memory and regulatory T cells. Concurrently, SDp, particularly children, demonstrate increased proinflammatory NK cells, inadequate expansion of CD16 + monocytes, and high expression of the FcγR CD64 on myeloid cells, yet a signature of diminished antigen presentation. Syndrome-specific determinants include suppressed dendritic cell abundance in shock/hemorrhage versus enriched plasma cell expansion in organ impairment. This study reveals uncoordinated immune responses in SDp and provides insights into SD pathogenesis in humans with potential implications for prediction and treatment.


  • Open Access

    Specimen sharing for epidemic preparedness: building a local-to-global virtual biorepository framework

    by Judith Giri, Laura Pezzi, Rodrigo Cachay, Rosa Margarita Gèlvez Ramirez, Adirana Tami, Sarah Bethencourt, Anylea Lozano, Julia Poje, Thomas Jaenisch, May Chu

    We present a framework for a federated, virtual biorepository system (VBS) with locally collected and maintained specimens, based on a ‘global goods’ model and principles of equitable access and benefit sharing. The VBS is intended to facilitate timely access to biological specimens and associated data for outbreak-prone infectious diseases to accelerate the development and evaluation of diagnostics, assess vaccine efficacy, and to support surveillance and research needs. The VBS is aimed to be aligned with the WHO BioHub and other specimen sharing efforts as a force multiplier to meet the needs of strengthening global tools for countering epidemics. The purpose of our research is to lay the basis of the collaboration, management and principles of equitable sharing focused on low- and middle-income country partners. Here we report on surveys and interviews undertaken with biorepository-interested parties to better understand needs and barriers for specimen access and share examples from the ZIKAlliance partnership on the governance and operations of locally organized biorepositories.

  • Open Access

    Development and Validation of a Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in the Americas

    by Ankita Reddy, Irene Bosch, Nol Salcedo, Bobby Brooke Herrera, Helena de Puig, Carlos F. Narváez, Diana María Caicedo-Borrero, Ivette Lorenzana, Leda Parham, Kimberly García, et al.

    Since its 2013 emergence in the Americas, Chikungunya virus (CHIKV) has posed a serious threat to public health. Early and accurate diagnosis of the disease, though currently lacking in clinics, is integral to enable timely care and epidemiological response. We developed a dual detection system: a CHIKV antigen E1/E2-based enzyme-linked immunosorbent assay (ELISA) and a lateral flow test using high-affinity anti-CHIKV antibodies. The ELISA was validated with 100 PCR-tested acute Chikungunya fever samples from Honduras. The assay had an overall sensitivity and specificity of 51% and 96.67%, respectively, with accuracy reaching 95.45% sensitivity and 92.03% specificity at a cycle threshold (Ct) cutoff of 22. As the Ct value decreased from 35 to 22, the ELISA sensitivity increased. We then developed and validated two lateral flow tests using independent antibody pairs. The sensitivity and specificity reached 100% for both lateral flow tests using 39 samples from Colombia and Honduras at Ct cutoffs of 20 and 27, respectively. For both lateral flow tests, sensitivity decreased as the Ct increased after 27. Because CHIKV E1/E2 are exposed in the virion surfaces in serum during the acute infection phase, these sensitive and specific assays demonstrate opportunities for early detection of this emerging human pathogen.


  • Open Access

    Development and Validation of A Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in The Americas

    by Ankita Reddy, Irene Bosch, Nol Salcedo, Bobby Brooke Herrera, Helena de Puig, Carlos Narváez, Diana Maria Caicedo-Borrero, Ivette Lorenzana, Leda Parham, Kimberly García, et al.

    Since its 2013 emergence in the Americas, chikungunya virus (CHIKV) has posed a serious threat to public health. Early and accurate diagnosis of the disease, though currently lacking in clinics, is integral to enable timely care and epidemiological response. We developed a dual detection system: a CHIKV antigen E1/E2-based enzyme-linked immunosorbent assay (ELISA) and a lateral flow test using high-affinity anti-CHIKV antibodies. The ELISA was validated with 100 PCR-tested acute Chikungunya fever samples from Honduras. The assay had an overall sensitivity and specificity of 51% and 96.67%, respectively, with accuracy reaching 95.45% sensitivity and 92.03% specificity at a Ct cutoff of 22. As the Ct value increased from 22, ELISA sensitivity decreased. We then developed and validated two lateral flow tests using independent antibody pairs. The sensitivity and specificity reached 100% for both lateral flow tests using 39 samples from Colombia and Honduras at Ct cutoffs of 20 and 27, respectively. For both lateral flow tests, sensitivity decreased as the Ct increased after 27. Because CHIKV E1/E2 are exposed in the virion surfaces in serum during the acute infection phase, these sensitive and specific assays demonstrate opportunities for early detection of this emerging human pathogen.